Dr. A C Ramesh mentions The Nail Society of India (NSI) recommendations for the pharmacologic management of onychomycosis provide a structured, evidence-based framework to guide clinical decision-making. These recommendations emphasize accurate diagnosis, appropriate patient selection, and the rational use of topical and systemic antifungal therapies based on disease severity and nail involvement. By incorporating current evidence and expert consensus, the guidelines aim to improve treatment outcomes, minimize recurrence, and enhance patient adherence. As clinicians, aligning practice with these recommendations can help ensure standardized, effective, and patient-centered care for individuals with onychomycosis